A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-Resistant Depression

This study has been completed.

Study NCT00044681 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: September 3, 2002 Last Updated: May 18, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	March 2004
Estimated Primary Completion Date:	No date given